Cargando…
Control of HCV Replication With iMIRs, a Novel Anti-RNAi Agent
MicroRNAs (miRNAs) serve important roles in regulating various physiological activities through RNA interference (RNAi). miR-122 is an important mediator of RNAi that is known to control hepatitis C virus (HCV) replication and is being investigated in clinical trials as a target for anti-HCV therapy...
Autores principales: | Itami, Saori, Eguchi, Yutaka, Mizutani, Takayuki, Aoki, Eriko, Ohgi, Tadaaki, Kuroda, Masahiko, Ochiya, Takahiro, Kato, Nobuyuki, Suzuki, Hiroshi I, Kawada, Norifumi, Murakami, Yoshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345303/ https://www.ncbi.nlm.nih.gov/pubmed/28110745 http://dx.doi.org/10.1038/mtna.2014.71 |
Ejemplares similares
-
A novel platform to enable inhaled naked RNAi medicine for lung cancer
por: Fujita, Yu, et al.
Publicado: (2013) -
Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Murakami, Yoshiki, et al.
Publicado: (2015) -
Circulating Exosomal miRNA Profiles Predict the Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with Direct-Acting Antiviral-Induced Sustained Viral Response
por: Itami-Matsumoto, Saori, et al.
Publicado: (2019) -
Efficacy of a Novel Class of RNA Interference Therapeutic Agents
por: Hamasaki, Tomohiro, et al.
Publicado: (2012) -
The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis
por: Murakami, Yoshiki, et al.
Publicado: (2013)